Crossmark

Predictive value of cardiometabolic index combined with N-Terminal pro-B-Type natriuretic peptide for moderate- to high-risk patients with acute coronary syndrome

Crossref DOI link: https://doi.org/10.1186/s12872-026-06244-3

Published Online: 2026-07-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

chen, Juanya

Dai, Meifen

Gao, Limei

Li, Lishan

Shan, Lihua

Liu, Zirong
License Information

Text and Data Mining valid from 2026-07-28

Accepted Manuscript valid from 2026-07-28
More Information

Article History

Received: 8 May 2026

Accepted: 3 July 2026

First Online: 28 July 2026

Declarations

Ethics approval and consent to participate: The study complied with the Declaration of Helsinki. This retrospective study utilized anonymized clinical data from the electronic medical record system of the Sixth Affiliated Hospital of South China University of Technology. Because the study involved no direct patient contact or intervention and all data were de-identified prior to analysis, the need for informed consent and formal ethical approval was waived by the hospital’s Ethics Committee. Clinical Trial Number: Not applicable. This study is a retrospective study and was not registered on any clinical trial platform.

Consent for publication: The participants voluntarily participated in this study and signed the informed consent form.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below